Two new studies being presented at the 2025 American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting in Orlando shed light on how hereditary angioedema (HAE) – a rare, ...

Two new studies presented at the 2025 American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting in ...

Optimize your hereditary angioedema (HAE) care management with the help of an allergist-immunologist, PCP, gastroenterologist ...

Hereditary angioedema (HAE) is a genetic condition that causes bouts of swelling in the tissue under your skin. The uncomfortable swelling can happen in many different parts of your body, including ...

Please provide your email address to receive an email when new articles are posted on . Patients fit into one of four groups based on monthly hereditary angioedema attacks before lanadelumab. Along ...

Hereditary angioedema (HAE) doesn’t just cause swelling and discomfort; it also brings uncertainty to everyday life. This rare genetic condition causes sudden swelling attacks that are unpredictable, ...

Argo Biopharmaceutical Co., Ltd. (Argo Biopharma), a clinical-stage small interfering RNA (siRNA) therapeutics company, today announced it will present Phase I data for BW-20805 at the American ...

Donidalorsen is the first RNA-targeted prophylactic treatment approved for hereditary angioedema, offering significant attack rate reduction. The OASIS-HAE study showed an 81% reduction in HAE attacks ...

Trading in shares of Ionis Pharmaceuticals is halted Thursday ahead of an expected decision from the U.S. Food and Drug Administration on the company's proposed donidalorsen treatment for hereditary ...

Two new studies being presented at the 2025 American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific ...